ClearCancer Solution
Private Health Management
Dr. Gertsik is an accomplished healthcare professional with expertise in population health risk management, healthcare services, workforce health, & biopharmaceuticals. At PHM, Natalya leads our ClearCancer™ Solution to support organizations in providing the best of what’s possible in cancer care to their members. Natalya advises employers on emerging and chronic health risks, providing actionable guidance to optimize cancer care at both the organizational and individual level. This includes improving cancer outcomes and reducing wasteful medical spend, benefits and formulary design, precision medicine adoption, case management approaches, and the use of the latest early detection technologies.
Dr. Gertsik is an accomplished healthcare professional with expertise in population health risk management, healthcare services, workforce health, & biopharmaceuticals. At PHM, Natalya leads our ClearCancer™ Solution to support organizations in providing the best of what’s possible in cancer care to their members. Natalya advises employers on emerging and chronic health risks, providing actionable guidance to optimize cancer care at both the organizational and individual level. This includes improving cancer outcomes and reducing wasteful medical spend, benefits and formulary design, precision medicine adoption, case management approaches, and the use of the latest early detection technologies.
Prior to joining PHM, Natalya was a management consultant at McKinsey & Company where she worked across industries including biopharmaceuticals, health insurance and the social sector. She received her Bachelor of Arts in Biochemistry from New York University and her Doctorate in Biochemistry from Weill Cornell Graduate School of Medical Sciences. Her PhD work focused on Alzheimer’s disease drug development and helped illuminate the reasons behind a high-profile Alzheimer’s disease drug failure in late-stage clinical trials. Her findings were published in the journal of Cell Chemical Biology. Natalya is a member of the Business Group on Health’s Evidence-Based Benefit Design Committee.
Tuesday, January 23, 2024
3:00pm - 3:45pm ET